---
layout: post
title: "Evaluating the Safety of Antimicrobial New Animal Drugs With Regard to Their Microbiological Effects on Bacteria of Human Health Concern; Revised Draft Guidance for Industry; Availability"
date: 2026-02-05 19:01:55 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-27415
original_published: 2022-12-19 00:00:00 +0000
significance: 8.00
---

# Evaluating the Safety of Antimicrobial New Animal Drugs With Regard to Their Microbiological Effects on Bacteria of Human Health Concern; Revised Draft Guidance for Industry; Availability

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** December 19, 2022 00:00 UTC
**Document Number:** 2022-27415

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry #152 entitled "Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern." This draft guidance informs stakeholders about FDA's current method for evaluating potential microbiological effects of antimicrobial new animal drugs on bacteria of human health concern as part of the new animal drug application process.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/12/19/2022-27415/evaluating-the-safety-of-antimicrobial-new-animal-drugs-with-regard-to-their-microbiological-effects)
- API: https://www.federalregister.gov/api/v1/documents/2022-27415

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
